Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters

Background: Unfractionated heparin (UFH) is used as an anticoagulant during the atrial fibrillation (AF) ablation procedure to prevent the occurrence of thromboembolic events. Guidelines recommend an activated clotting time (ACT) greater than 300 s (s) based on studies of patients treated with vitam...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Marie, Godet, Julien, Delabranche, Xavier, Sattler, Laurent, Millard, David, Marzak, Halim, Mertes, Paul Michel, Steib, Annick, Grunebaum, Lelia, Jesel, Laurence, Tacquard, Charles Ambroise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054854/
https://www.ncbi.nlm.nih.gov/pubmed/36983237
http://dx.doi.org/10.3390/jcm12062236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054854/
https://www.ncbi.nlm.nih.gov/pubmed/36983237
http://dx.doi.org/10.3390/jcm12062236

Ejemplares similares